Closed · RFA-DP-16-002 · CFDA 93.283 · Discretionary
Michigan Lupus Epidemiology and Surveillance (MILES) Program Longitudinal Cohort Study
Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.
- $750K-$1M
- Award range
- Closed
- Status
- February 10, 2016
- Close date
- 1
- Expected awards
The verdict
Michigan Lupus Epidemiology and Surveillance (MILES) Program Longitudinal Cohort Study is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered $750,000 -- $1,000,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 639 other opportunities from Centers for Disease Control and Prevention - ERA.
- $750K-$1M
- award range
- Closed
- application status
- 1
- expected award
- 93.283
- CFDA program
Archived opportunity record
Michigan Lupus Epidemiology and Surveillance is closed (last close February 10, 2016). The parent program page for CFDA 93.283 is the reliable place to catch re-announcements. Centers for Disease Control and Prevention - ERA still indexes 639 other opportunities here.
According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.
Deadline tracker
Application window closed
Closed February 10, 2016
Est. Total Funding
$3,000,000
Expected Awards
1
Instrument
Cooperative Agreement
Description
Lupus is a prototypical autoimmune disease with a wide spectrum of illness that can be limited to the skin or can affect almost any tissue and organ in the body and cause severe morbidity and premature mortality. While there are several forms of lupus, systemic lupus erythematous (SLE) is the most common and serious form of lupus and has a variety of clinical manifestations. SLE affects from 320,000 to 1.5 million Americans and has strong disparities in incidence and prevalence, affecting women far more than men and minorities more than whites. The causes of SLE are unknown but are believed to be linked to genetic, environmental, and hormonal factors. Much of what is known about SLE comes from convenience samples and tertiary care centers that are not population-based and therefore biased toward the severe end of the disease spectrum. As a result there is a need for a basic epidemiologic understanding of SLE in order to understand the full clinical spectrum and population burden of the disease. The purpose of this funding announcement is to support a longitudinal study to follow an established population-based cohort with SLE to determine over time: 1) the treatment, health care access, and natural history (severity, morbidity, mortality, etc.) of lupus (systemic lupus erythematosus) and related outcomes; 2) factors (including genetic and other biological factors such as antibody levels) associated with outcomes of treatment, health care access and natural history; and 3) potential disparities and other factors associated with outcomes by categories of interest (e.g., gender and race/ethnic group).
Catch-all / unrestricted eligibility mark · RFA-DP-16-002
Grants.gov marks Michigan Lupus Epidemiology and Surveillance with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Centers for Disease Control and Prevention - ERA book (299 peers, 47% of 640).
- Code 25
- Others (see official listing text)
Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Parent Grant Program
Centers for Disease Control Investigations and Technical Assistance
Centers for Disease Control and Prevention
Agency Contact
Sue Shaw ZGX7@cdc.gov
More from Centers for Disease Control and Prevention - ERA
US Travelers Health Research, Surveillance, Communication, and Outreach Network
Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
Occupational Safety and Health Training Project Grants (T03)
Occupational Safety and Health Education and Research Centers (T42)
RFA-PS-18-000
What to do next
Michigan Lupus Epidemiology and Surveillance is closed; use the parent program and agency catalog for the next funding cycle.
- Parent CFDA 93.283 may publish future NOFOs under the same assistance listing. Open program
- Centers for Disease Control Investigations an… indexes 3 Grants.gov listings in this extract. Program profile
- Centers for Disease Control and Prevention - ERA lists 639 other indexed opportunities on PlainGrants. Agency catalog
Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |